List of Pharmaceutical Companies in Serbia ICH GCP
- Classification:Chemical Auxiliary Agent, Chemical Auxiliary Agent
- cas no 117-84-0
- Other Names:DOP, diocty phthalate, 1,2-phthalate
- MF:C6H4(COOC8H17)2
- EINECS No.:201-557-4
- Purity:99.6%
- Type:Plastic Auxiliary Agents
- Usage:Leather Auxiliary Agents, Paper Chemicals, Plastic Auxiliary Agents, Rubber Auxiliary Agents, Textile Auxiliary Agents
- MOQ::10 Tons
- Package:25kg/drum
- Shape:Powder
- Volume Resistivity:161
- Item:T/T,L/C
Global Pharmaceutical Companies in Serbia. AbbVie. We’re a company that takes on the toughest health challenges. But we do more than treat diseases—we aim to make a
List of top Pharmaceutical companies in Serbia In this section, you’ll find the list of some of the top pharmaceutical companies in Serbia among the thousands of companies that have been established in the country. Allergan. Address:
Full List of Pharmaceutical Companies in Serbia
- Classification:Chemical Auxiliary Agent
- CAS No.:117-84-0
- Other Names:DOP, Dioctyl phthalate
- MF:C24H38O4
- EINECS No.:201-557-4
- Purity:99.99, 99%
- Type:Plastic Auxiliary, Dop Plasticizer For Pvc
- Usage:Coating Auxiliary Agents, Plastic Auxiliary Agents, Rubber Auxiliary Agents
- MOQ:200kgs
- Package:200kgs/battle
- Place of Origin::China
- Advantage:Stable
Serbia is the home to Galenika a.d and Hemofarm a.d. (STADA Group), one of the largest manufacturing pharmaceutical companies in Serbia, with a presence in 30 countries. They manufacture both OTC and prescription
List of Pharmaceutical Companies and representative ofices of global pharmaceutical companies in Serbia
Bone Graft Substitutes Companies Market
- Classification:Chemical Auxiliary Agent, Chemical Auxiliary Agent
- cas no 117-84-0
- Other Names:DOP, diocty phthalate, 1,2-phthalate
- MF:C24H38O4
- EINECS No.:201-557-4
- Purity:99.5, ≥99.5
- Type:Adsorbent, plasticizer
- Usage:PVC Products, Coating Auxiliary Agents, Leather Auxiliary Agents,
- MOQ::10 Tons
- Package:25kg/drum
- Shape:Powder
- Place of Origin::China
- Item:T/T,L/C
In-depth analysis of global and regional trends Analyze and identify the major players in the market, their market share, key developments, etc. Bone graft substitute companies specialize in the development and manufacturing of
The list is dominated by big corporations (98), which generated 98.6% of the operating income of the listed companies. Of the observed hundred companies, the majority is creditworthy (62), with 35 having a good credit
Dioctyl Phthalate (DOP): 2024 World Market
- Classification:Chemical Auxiliary Agent
- CAS No.:117-84-0
- Other Names:Dioctyl Phthalate DOP
- MF:C24H38O4, C24H38O4
- EINECS No.:201-557-4
- Purity:99.6%, 99.6%
- Type:Plastic Auxiliary, Dop Plasticizer For Pvc
- Usage:Plastic Auxiliary Agents, Plasticizer
- MOQ:200kgs
- Package:200kgs/battle
- Shape:Powder
9. KEY COMPANIES IN THE DIOCTYL PHTHALATE MARKET WORLDWIDE Each company analysis covers (depending on data availability): Company overview Business segmentation Company SWOT analysis Dioctyl
This list of companies and startups in Serbia provides data on their funding history, investment activities, and acquisition trends. Insights about top trending companies, startups, investments
Top 100 companies: Serbia Statista
- Classification:Chemical Auxiliary Agent
- CAS No.:117-84-0
- Other Names:Dop
- MF:C24H38O4, C24H38O4
- EINECS No.:201-557-4
- Purity:99%
- Type:Plasticizer, Dioctyl Phthalate
- Usage:Petroleum Additives, Plastic Auxiliary Agents, Rubber Auxiliary Agents
- MOQ:200kgs
- Package:200kgs/battle
- Shape:Powder
- Payment:T/T
- Certificate::COA
In 2023, Serbia had a population of 6.82 million and a GDP per capita of US$10,849.99. The number of large companies in Serbia is an indicator of its overall economic performance.
This market report lists the top Global Bone Substitutes companies based on the 2023 & 2024 market share reports. DBMR Analyst after extensive analysis have determined these companies as leaders in the Global Bone Substitutes market based of brand shares.
- How can Serbian pharmaceutical companies benefit from global trends?
- Serbian pharmaceutical companies have strategically positioned themselves to benefit from global trends in the industry. Companies such as Hemofarm and Galenika, which have invested significant capital in development, expand the borders of medicine in the region.
- Who makes Genezis in Serbia?
- Serbia is the home to Galenika a.d and Hemofarm a.d. (STADA Group), one of the largest manufacturing pharmaceutical companies in Serbia, with a presence in 30 countries. They manufacture both OTC and prescription medicines. Genezis is an association of generic and biosimilar drug makers in Serbia and Montenegro.
- How big is the pharmaceutical industry in Serbia?
- The industry and pharmaceutical companies in Serbia have an estimated market size of €833 million, with an expected growth of 6.7% from 2019 to 2021. Prescription medications account for the majority of sales well ahead of 0TC drugs.
- Which public companies have lost the most money in Serbia?
- The company that generated the biggest losses is Elektroprivreda Srbije (EPS). Other public enterprises that recorded the biggest losses include Roads of Serbia (JP Putevi Srbije), GSP Beograd (Belgrade public transport company), JP PEU Resavica (mining company) and JP Elektrokosmet (power company).
- How is the manufacture and trade of drugs regulated in Serbia?
- The manufacture and trade of drugs and other pharmaceutical products are regulated by the Drugs and Health Products Act (in force since August 1, 2004). With this law, the Agency for Medicines and Health Products of Serbia was established to bring national regulations into line with EU standards.